

LIVE WEBINAR
Melting the Future of Viral Vectors: Beyond Frozen Storage
November 24, 2026
16:00 CET / 10:00 AM ET / 7:00 AM PT
45-min live session
Interactive Decision Case
Live Q&A
Register now

We bring extensive experience in stabilizing conjugated biologics across a wide range of payload classes and linker technologies. Our team develops both liquid and lyophilized formulations tailored to your ADC’s specific characteristics. We integrate:
● Molecular Modeling of protein, and drug conjugated protein to evaluate change of characteristics
● Holistic analytical characterization (antibody, linker, payload).
● Stability profiling across stress conditions.
● Formulation design to minimize degradation and aggregation.
● Robust formulation pathways aligned with target product profile.
Key Focus Areas
-
1. Feasibility assessment: Molecular modeling and molecule characterization, risk identification, and early excipient strategy.
2. Formulation optimization: iterative DoE for stability, potency preservation, and manufacturability.
3. Stability programs: ICH Q1-aligned long-term accelerated and forced degradation studies.
4. Handling and scale-up: safe OEB 5 processes and Fill&Finish ready formulation packages.

